White label ELPA - ClinicalTrials.eu

Phase 2 Study of Daxdilimab with Prednisone in Adults with Inadequately Controlled Dermatomyositis or Anti‑Synthetase Inflammatory Myositis

Not recruiting

2 1 1
Investigated Diseases:
Investigated Drugs:
- Daxdilimab
- Prednisone
Durvalumab versus standard chemotherapy drug combination in elderly patients with advanced non‑small cell lung cancer

Not recruiting

2 1 1 1
Investigated Drugs:
Preventing Heart Failure in Early Breast Cancer Patients Receiving Anthracycline Therapy with Sacubitril and Valsartan (LCZ696)

Not recruiting

2 1 1
Investigated Diseases:
- Breast cancer female
- Cardiac failure
Investigated Drugs:
- Sacubitril
- Valsartan
Study of alpelisib with trastuzumab and pertuzumab as maintenance therapy in adult patients with HER2‑positive advanced breast cancer and PIK3CA mutation

Not recruiting

3 1 1 1
Investigated Diseases:
- Breast cancer
Investigated Drugs:
Gedatolisib plus drug combination for HR‑positive, HER2‑negative advanced breast cancer patients whose disease progressed after CDK4/6 inhibitor therapy

Not recruiting

3 1 1 1
Investigated Diseases:
- Hormone receptor positive HER2 negative breast cancer
- Hormone receptor positive breast cancer
Investigated Drugs:
+6
Oral Semaglutide in People With Mild Cognitive Impairment or Mild Dementia of the Alzheimer’s Type

Not recruiting

3 1 1
Investigated Drugs:
- Semaglutide
+15
JNJ-95597528 for Adults with Moderate to Severe Atopic Dermatitis

Not recruiting

2 1
A Phase 2 Study of JNJ-79635322 in Patients with Relapsed or Refractory Multiple Myeloma

Not recruiting

2 1 1
Investigated Drugs:
- IGG1 TRISPECIFIC MONOCLONAL ANTIBODY AGAINST T-CELL RECEPTOR CD3, B-CELL MATURATION ANTIGEN AND G PROTEIN-COUPLED RECEPTOR CLASS C GROUP 5 MEMBER D
ORKA-001 in Patients with Moderate-to-Severe Plaque Psoriasis

Not recruiting

2 1
Investigated Diseases:
- Psoriasis
Phase 3 study of ianalumab plus standard drug combination in adults and adolescents with systemic lupus erythematosus

Not recruiting

3 1 1
Investigated Drugs:
+1

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies